Prescription medication
Article
Licit and illicit quetiapine use among IDRS participants
This paper presents a preliminary examination of the use of quetiapine (an antipsychotic drug) amongst a broader sample of people who inject drugs.
Report
A review of opioid prescribing in Tasmania: a blueprint for the future
This review of the evidence on opioid medications in Tasmania, and also nationally and internationally, has brought up a number of important observations on the changing landscape in Schedule 8 (S8) opioid medication availability, prescribing, and the changes in the regulation of these potent medications that have occurred in Australian jurisdictions and internationally.
Report
Patterns of asthma medication use in Australia
This report describes the first study to use national data from the Pharmaceutical Benefits Scheme (PBS) to investigate the patterns of asthma medication use in Australia.
Report
Medication for attention deficit/hyperactivity disorder: an analysis by federal electorate (2001-03)
For some time, considerable disparity has been apparent in the prescribing of medication for children with attention deficit/hyperactivity disorder in different jurisdictions in Australia. Despite having a smaller population than New South Wales, Victoria and Queensland, Western Australia accounts for the highest number of prescriptions dispensed for dexamphetamine sulfate, a drug prescribed to treat ADHD...
Policy report
National Medicines Policy
Australia's National Medicines Policy is a cooperative endeavour to bring about better health outcomes for all Australians, focusing especially on people’s access to, and wise use of, medicines. The term “medicine” includes prescription and non-prescription medicines, including complementary healthcare products.